Fig. 3
From: Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
Reprinted (adapted) with permission from Wang et al. [83]. (Copyright © 2021 Wang et al. Journal of Nanobiotechnology published by BioMed Central). http://creativecommons.org/licenses/by/4.0/
AÂ Preparation of Pt@mPDA/MnO2/PDA-ZHer2 NPs and in vivo MRI-guided enhanced chemo-radiotherapy. BÂ a Schematic illustration of process of the chemo-radiation combined therapy; b SKOV-3 tumor growth curves of different groups after intravenously injection of the formulations; c The images of tumors isolated after treatment for 8 days; d Mean weights of the tumors isolated on day 14; e Body weight changes over the 8 days of the experiments.